4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000047
CEO bought 119,000 shares at an average $0.01 ($1,226)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
16 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-23 | Purchase : show line 1 in the form | +10,000 | $0.01 | $102 | 25,075,297 | D |
| 2019-08-23 | Purchase : show line 2 in the form | +2,000 | $0.01 | $21 | 25,077,297 | D |
| 2019-08-26 | Purchase : show line 3 in the form | +5,000 | $0.01 | $52 | 25,082,297 | D |
| 2019-08-26 | Purchase : show line 4 in the form | +5,000 | $0.01 | $52 | 25,087,297 | D |
| 2019-08-26 | Purchase : show line 5 in the form | +10,000 | $0.01 | $104 | 25,097,297 | D |
| 2019-08-26 | Purchase : show line 6 in the form | +2,000 | $0.01 | $20 | 25,099,297 | D |
| 2019-08-27 | Purchase : show line 7 in the form | +15,000 | $0.01 | $155 | 25,114,297 | D |
| 2019-08-27 | Purchase : show line 8 in the form | +10,000 | $0.01 | $104 | 25,124,297 | D |
| Open-market purchases · 119,000 sh · avg $0.01 · $1,226 | ||||||
Loading xslF345X03/primary_doc.xml…